Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
& Trautmann, M
Damin MR, Cortes-Perez NG, Quintana ET, Ortiz-Moreno A, Garfias Noguez C, Cruceo-Casarrubias CE, Snchez Pardo ME, Bermdez-Humarn LG (2022) Functional foods, nutraceuticals and probiotics: a focus on human health
The main safety concern is the unknown effect on melanocytes (pigment-producing cells), particularly in people with a history of melanoma or atypical moles
17 Rosenstock, J., et al., Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
US$ 22.93
US$ 26.66
US$ 23.63
US$ 27.73
